Ram Narayan, MD
Radiation Oncology · Merrillville, INNPI 1376954693
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,050 of the $1,591 with a category attached, or 66.0%. AstraZeneca accounts for 66.0% of it on its own, with 16 other manufacturers making up the rest. 2024 is the largest year on record at $1,050, more than ten times the $57 reported in 2019.
Across 23 payments — averaging $69.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Myriad Genetic Laboratories, Inc.$169
- Seagen Inc.$101
- Merck$40
- Cardinal Health 414 LLC$35
- Boston Scientific$25
- plus $170 from 11 others
What the payments were for
- Consulting fees$1,05066%
- Food & beverage$44228%
- Education$996%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 2 | $1,050 |
| Myriad Genetic Laboratories, Inc. | 3 | $169 |
| Seagen Inc. | 2 | $101 |
| Merck | 2 | $40 |
| Cardinal Health 414 LLC | 2 | $35 |
| Boston Scientific | 1 | $25 |
| Myovant Sciences Inc. | 1 | $21 |
| Novartis | 1 | $19 |
| Novocure Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Gilead | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| Blue Earth Diagnostics | 1 | $15 |
| Amgen | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $13 |
| Puma Biotechnology, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,591 in reported general payments places this provider in the 70th percentile of 116 radiation oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mometasone Furoate | 27 | $385 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Merrillville
- Robert WoodburnMerrillville$2K
- Brian ChangFort Wayne$13K
- Michael EatonIndianapolis$11K
- William PorterMadison$8K
- Binh TranMishawaka$7K
- Gordon WatsonIndianapolis$6K
- John CoxIndianapolis$5K
- Houman VaghefiGoshen$5K
- Peter GarrettIndianapolis$5K
- Garrett JensenIndianapolis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.